Scott Giacobello

Scott Giacobello

Director of Finance/CFO at WHITEHAWK THERAPEUTICS, INC.

Net worth: 2 M $ as of 30/06/2026

55 year
Health Technology
Commercial Services
Consumer Services

Profile

Scott M. Giacobello holds the position of Chief Financial Officer & Head-Investor Relations for GW Pharmaceuticals Plc. Mr. Giacobello is also on the board of Autobahn Therapeutics, Inc. He previously held the position of Chief Financial Officer of Chase Pharmaceuticals Corp. and VP-Global Research & Development Finance at Allergan Plc. He received an undergraduate degree from Notre Dame Academy.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/05/2026 333,489 ( 0.71% ) 2 M $ 30/06/2026

Scott Giacobello active positions

CompaniesPositionStart
WHITEHAWK THERAPEUTICS, INC. Director of Finance/CFO 28/11/2021
Director/Board Member 05/01/2021

Former positions of Scott Giacobello

CompaniesPositionEnd
GW PHARMACEUTICALS PLC Director of Finance/CFO 01/05/2021
Director of Finance/CFO 01/11/2016
ALLERGAN PLC Director of Finance/CFO -
Director/Board Member -
See the detail of Scott Giacobello's experience

Training of Scott Giacobello

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Scott Giacobello